RecruitingNCT04612296

The Heart Hive - Cardiomyopathy Study

A Longitudinal Observational Study of Self-reported Cardiomyopathy in the Heart Hive


Sponsor

Imperial College London

Enrollment

10,000 participants

Start Date

Nov 9, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of cardiomyopathies.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Adult (age 18 and over),
  • Males and Females,
  • Capacity to provide informed consent,
  • Patients with a confirmed diagnosis of cardiomyopathy or myocarditis,
  • People with a family history of cardiomyopathy confirmed in a first or second degree relative.
  • Note: Pregnant women are eligible. This study is observational and entirely separate from clinical care.

Exclusion Criteria7

  • Patients who lack capacity to consent for themselves,
  • Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill).
  • Patients with a confirmed history of coronary artery disease:
  • who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or
  • who have undergone previous percutaneous coronary intervention or coronary bypass surgery
  • History of primary valvular heart disease or congenital heart disease
  • Severe, untreated or untreatable hypertension (systolic blood pressures routinely \>180 mm Hg and/or diastolic blood pressures \>120 mm Hg)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICResearch genetic analysis

Genetic analysis of DNA extracted from saliva. Participants can opt in to receive individual results of research genetic analysis for a predefined panel of clinically actionable cardiomyopathy genes.


Locations(1)

Imperial College London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04612296


Related Trials